দেশ: যুক্তরাজ্য
ভাষা: ইংরেজি
সূত্র: VMD (Veterinary Medicines Directorate)
Ramipril
aniMedica GmbH
QC09AA05
Ramipril
Tablet
POM-V - Prescription Only Medicine – Veterinarian
Dogs
Cardio Vascular ACE inhibitor
Expired
2012-07-18
Revised: March 2017 AN: 00124/2016 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Prilocard 1.25mg tablets for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Active substance: Ramipril 1.25 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablets. White round biconvex tablets, imprinted with ‘B’ on one side of the tablet and ‘48’ on the other. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For treatment of congestive heart failure (equivalent to New York Heart Association [NYHA] classes II, III and IV) caused by valvular insufficiency due to endocardiosis or cardiomyopathy. The preparation may if applicable be administered concomitantly with furosemide (diuretic) and/or the cardiac glycosides digoxin or methyl digoxin. Class Clinical symptoms II Fatigue, dyspnoea, cough etc. seen in normal activity. Ascites may occur at this stage. III Comfortable at rest, but capacity for activity minimal. IV Incapable of any activity. Clinical symptoms of disablement occur even at rest. In patients treated concomitantly with ramipril and furosemide, the diuretic dose may be reduced to achieve the same diuretic effect as in treatment with furosemide alone. Revised: March 2017 AN: 00124/2016 Page 2 of 6 4.3 CONTRAINDICATIONS Do not use in haemodynamically-related stenoses (e.g. aortic stenosis, mitral stenosis) nor in cases of obstructive hypertrophic cardiomyopathy. Do not use in cases of hypersensitivity to the active substance, ACE-inhibitors or to any of the excipient(s). See Section 4.7 for use in Pregnancy and Lactation 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS If symptoms of apathy and ataxia (potential symptoms of hypotension) occur during treatment with ramipril, administration of the preparation should be stopped and resumed at only 50% of the original dose as soon as the symptoms hav সম্পূর্ণ নথি পড়ুন